 |
市場調查報告書
商品編碼
1907819
週邊血管支架市場：市場規模、佔有率、監管、報銷、介入治療及至2036年預測（按細分市場劃分）Peripheral Vascular Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
週邊血管支架市場（規模、佔有率、監管、報銷、介入治療及至2036年預測）旨在展現心血管器械治療領域的定量和定性市場趨勢。
週邊血管支架是一種可擴張的帶孔管，插入週邊血管以防止血流受阻。由於人口老化、已開發國家疾病高發生率以及新型診斷方法的出現，微創治療方法（如血管成形術和支架置入術）的應用日益增加。用於治療週邊動脈疾病 (PAD) 的微創技術包括球囊血管成形術、支架置放術和斑塊切除術。這些治療方法恢復時間短，感染和出血風險低，因此在臨床實踐中廣泛應用。球囊血管成形術和支架植入術已取代侵入性動脈繞道手術，成為週邊動脈疾病 (PAD) 患者的第一線治療方案。這些微創手術用於疏通身體各部位（包括腿部、腎臟和頸動脈）的狹窄或阻塞動脈。週邊支架植入術是將支架插入阻塞的周邊動脈，擴張血管，恢復正常血流。由於球囊血管成形術有彈性回縮和新生內膜增生等問題，支架植入術已成為首選方案。
39 個國家的市場模型均採用顏色編碼，並包含流行病學為基礎的適應症和介入量，以及完整的資料來源說明。互動式 Excel 表格提供價值、數量、產品利用率、平均售價、市場規模和公司佔有率分析（如有）。此外，分析師的評論和定性見解為定量數據提供了背景資訊。
市場模型的主要特徵包括：
外周支架的當前市佔率及不斷變化的競爭格局
- 對關鍵產業趨勢的深入分析
- 按細分市場劃分的周邊支架市場年度總收入及2015年至2036年的市場預測
- 按細分市場劃分的總手術量、單位銷售、平均售價和市場價值的詳細數據
全球、區域和國家層面的市場洞察
- 除了定性的市場特定資訊外，我們還提供按區域劃分的全球趨勢細分分析。此外，GlobalData 分析師還提供針對特定國家市場的獨特見解
- 外周支架市場的 SWOT 分析
- 外周支架市場的競爭格局及趨勢
透過全面、整體的視角，加深您對市場的理解，包括醫療保健系統概覽。此外， "市場准入" 部分透過報銷政策和監管環境訊息，讓您更深入地了解市場動態。
- 各國醫療保健系統概覽。
- 各國報銷政策。
- 各國醫療科技監管環境。
憑藉強大的研究方法和資料來源，該模型提供全面且準確的市場概覽。主要需求和供應方資訊（包括關鍵產業專家）已整合到該聯合模型中。此外，也利用真實世界資料來源來確定市場趨勢。這些資料來源包括政府程式資料庫、醫院採購資料庫和專有線上資料庫。
涵蓋的公司：W.L.戈爾公司 (Gore & Associates Inc.)、波士頓科學公司 (Boston Scientific Corp.)、巴德公司 (CR Bard Inc.)、威爾遜-庫克醫療公司 (Wilson-Cook Medical Inc.)、雅培實驗室 (Abbott Laboratories)、美敦力公司 (Medtronic Plc. (Biotronik SE & Co. KG)、京都醫療規劃株式會社 (Kyoto Medical Planning Co. Ltd.) 等。
其他。
涵蓋國家：美國、英國、德國、法國、義大利、西班牙、巴西、中國、印度、俄羅斯、日本、澳洲、加拿大、墨西哥、韓國、丹麥、愛爾蘭、荷蘭、紐西蘭、南非、瑞典、瑞士、奧地利、比利時、芬蘭、以色列、挪威、波蘭、葡萄牙、台灣、捷克、希臘、匈牙利、土耳其、埃及、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷和智利。
範圍
此市場模型提供其他地方無法獲得的關鍵專業知識。該模型揭示了特定市場內的定性和定量趨勢。本模型是以下人員的必讀之選：
- 需要深入了解週邊支架市場的首席行銷長 (CMO)，以便為策略規劃和投資決策提供資訊。
- 需要了解供應鏈關鍵組成部分以進行供應商選擇和管理決策的採購主管。
- 需要深入了解市場以識別和評估潛在投資目標的私募股權投資者。
購買理由
本模型可幫助您：
- 透過產品線審查識別關鍵公司，並制定和設計許可引進和許可輸出策略。
- 了解影響和驅動週邊支架市場的趨勢，並制定業務策略。
- 透過了解關鍵趨勢、創新產品和技術、市場細分以及未來可能影響週邊支架市場的公司，實現收入成長。
- 了解競爭格局並分析市場領導者的市場佔有率，以製定有效的銷售和行銷策略。
- 識別具有潛在強大產品組合的新興公司，並制定有效的應對策略以獲得競爭優勢。
- 追蹤2015年至2036年全球及各國外周支架市場的器材銷售情況。
- 識別最具整合、投資和策略聯盟機會的市場類別和細分市場，以優化您的銷售和行銷工作。
Peripheral Vascular Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
A peripheral vascular stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. The aging population, the high prevalence of the disease in developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally invasive techniques, such as angioplasty and stenting. Minimally invasive techniques used to treat peripheral artery disease (PAD) include balloon angioplasty, stenting, and atherectomy. These interventions have reduced recovery times and the risk of infection and bleeding, and are frequently used in clinical practice. Balloon angioplasty and stenting have replaced invasive artery bypass surgery as the first line of treatment for patients with PAD. These minimally invasive interventions are used to open narrowed and occluded arteries in many different parts of the body, including in the legs, kidneys, as well as carotid arteries. Peripheral stenting involves inserting a stent into the blocked peripheral artery to widen it and allow for normal blood flow through the vessel. Problems associated with balloon angioplasty, such as elastic recoil and neointimal hyperplasia, make stenting the preferable option.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Peripheral Vascular Stents market and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Peripheral Vascular Stents market revenue by segment and market outlooks from 2015-2036.
- Granular data on total interventions, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Peripheral Vascular Stents market.
- Competitive dynamics insights and trends provided Peripheral Vascular Stents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: W.L. Gore & Associates Inc ,Boston Scientific Corp, CR Bard Inc ,Wilson-Cook Medical Inc ,Abbott Laboratories ,Medtronic Plc, Getinge AB,Cordis Corp,Terumo Corp,Biotronik SE & Co KG,Kyoto Medical Planning Co Ltd
Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the Peripheral Vascular Stents marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Peripheral Vascular Stents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Vascular Stents market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Peripheral Vascular Stents market from 2015-2036.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
